Skip to main content

Advertisement

Log in

High‐grade Salivary Gland Adenocarcinoma Harboring ETV6-NTRK3 Fusion: Defined by Morphology or Molecular Aberration?

  • Letters to the Editor
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Todorovic E, Dickson BC, Weinreb I. Salivary gland cancer in the era of routine next-generation sequencing. Head Neck Pathol. 2020;14:311–20. https://doi.org/10.1007/s12105-020-01140-4.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Skálová A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34:599–608. https://doi.org/10.1097/PAS.0b013e3181d9efcc.

    Article  PubMed  Google Scholar 

  3. Cipriani NA, Blair EA, Finkle J, et al. Salivary gland secretory carcinoma with high-grade transformation, CDKN2A/B loss, distant metastasis, and lack of sustained response to crizotinib. Int J Surg Pathol. 2017;25:613–8. https://doi.org/10.1177/1066896917709350.

    Article  PubMed  Google Scholar 

  4. Skálová A, Vanecek T, Majewska H, et al. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes. Am J Surg Pathol. 2014;38:23–33. https://doi.org/10.1097/PAS.0000000000000088.

    Article  PubMed  Google Scholar 

  5. Luo W, Lindley SW, Lindley PH, et al. Mammary analog secretory carcinoma of salivary gland with high-grade histology arising in hard palate, report of a case and review of literature. Int J Clin Exp Pathol. 2014;7:9008–22.

    PubMed  PubMed Central  Google Scholar 

  6. Petersson F, Michal M, Grossmann P. A new hitherto unreported histopathologic manifestation of mammary analogue secretory carcinoma: “Masked MASC” associated with low-grade mucinous adenocarcinoma and low-grade in situ carcinoma components. Appl Immunohistochem Mol Morphol. 2016;24:6.

    Article  Google Scholar 

  7. Skálová A, Ptáková N, Santana T, et al. NCOA4-RET and TRIM27-RET are characteristic gene fusions in salivary intraductal carcinoma, including invasive and metastatic tumors: is intraductal correct? Am J Surg Pathol. 2019;43:1303–13. https://doi.org/10.1097/PAS.0000000000001301.

    Article  PubMed  Google Scholar 

  8. Simpson RHW. Salivary duct carcinoma: new developments—morphological variants including pure in situ high grade lesions; proposed molecular classification. Head Neck Pathol. 2013;7:48–58. https://doi.org/10.1007/s12105-013-0456-x.

    Article  PubMed Central  Google Scholar 

  9. Taverna C, Baněčková M, Lorenzon M, et al. MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics. Histopathology. 2020. https://doi.org/10.1111/his.14251.

    Article  PubMed  Google Scholar 

  10. Bell D, Ferrarotto R, Liang L, et al. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland. Virchows Arch. 2020;476:295–305. https://doi.org/10.1007/s00428-019-02640-7.

    Article  CAS  PubMed  Google Scholar 

  11. Cocco E, Scaltriti M, Drilon A. NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol. 2018;15:731–47. https://doi.org/10.1038/s41571-018-0113-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Niels J. Rupp.

Ethics declarations

Conflict of interest

NJR discloses an advisory board function and receipt of honoraria from F. Hoffmann-La Roche AG. The “SalvGlandDx” panel has been developed by a grant from the Iten-Kohaut-Foundation/University Hospital Zurich Foundation to NJR. All other authors declare that they have no conflict of interest.

Informed consent

The patient provided a written informed consent in accordance with the Declaration of Helsinki.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rupp, N.J., Nemes, C., Rushing, E.J. et al. High‐grade Salivary Gland Adenocarcinoma Harboring ETV6-NTRK3 Fusion: Defined by Morphology or Molecular Aberration?. Head and Neck Pathol 15, 1082–1084 (2021). https://doi.org/10.1007/s12105-021-01297-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-021-01297-6

Navigation